Fate Therapeutics, Inc. · NASDAQ:FATE
Valamehr Bahram sold 28,946 Fate Therapeutics, Inc. shares (Form 4)
Traded May 20, 2026 · Filed May 21, 2026
On May 20, 2026, Valamehr Bahram (Director, President and CEO) sold 28,946 Fate Therapeutics, Inc. shares at US$1.88 for US$54,418, leaving 635,762 shares. Filed May 21, 2026 (Form 4).
- Sold
- 28,946 shares
- Price
- US$1.88
- Value
- US$54,418
- Holding after
- 635,762 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Stock | Sale | 28,946 | US$1.88 | 635,762 | Direct |